跳转至内容
Merck
  • Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium.

Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium.

Japanese circulation journal (2000-12-08)
H Sakurai, M Kei, K Matsubara, K Yokouchi, K Hattori, R Ichihashi, Y Hirakawa, H Tsukamoto, Y Saburi
摘要

Cardiogenic shock developed in a 72-year-old Japanese woman during combination therapy with verapamil and atenolol for recurrent supraventricular arrhythmia. She had coronary atherosclerosis, liver cirrhosis and bradycardia-tachycardia syndrome. Despite of the high-dose catecholamines and counterpulsation, she progressively deteriorated. Bolus administration of intravenous calcium chloride (CaCl2) immediately resolved her hemodynamic collapse.

材料
货号
品牌
产品描述

Sigma-Aldrich
阿替洛尔, ≥98% (TLC), powder
Supelco
阿替洛尔标准溶液 溶液, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
USP
阿替洛尔, United States Pharmacopeia (USP) Reference Standard
阿替洛尔, European Pharmacopoeia (EP) Reference Standard